iShares Nasdaq Biotechnology ETF (IBB)

Add to Watchlists
Create an Alert
106.60 +1.43  +1.36% NASDAQ Dec 15, 20:00 Delayed 2m USD
View Full Chart
IBB Price Chart

IBB Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 4.42% 4.43% 2.87% 28
3M -3.59% -3.61% -0.44% 92
6M 8.95% 8.90% 6.52% 44
YTD 20.74% 20.87% 22.71% 65
1Y 17.87% 17.80% 22.35% 74
3Y 2.56% 2.56% 6.14% 90
5Y 18.46% 18.43% 16.85% 39
10Y 14.74% 14.74% 11.68% 18
As of Dec. 15, 2017. Returns for periods of 1 year and above are annualized.

IBB Asset Allocation

Type % Net % Long % Short
Cash 0.07% 0.07% 0.00
Stock 99.93% 99.93% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of Dec. 13, 2017

IBB Region Exposure

Americas 98.43%
North America 98.43%
Latin America 0.00
Greater Europe 1.25%
United Kingdom 0.58%
Europe Developed 0.61%
Europe Emerging 0.00
Africa/Middle East 0.05%
Greater Asia 0.32%
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.32%
Market Classification
% Developed Markets 99.68%
% Emerging Markets 0.32%
As of Dec. 13, 2017. Region breakdown data is calculated by using the long position holdings of the portfolio.

IBB Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 99.95%
Industrials 0.00
Real Estate 0.00
Technology 0.05%
Utilities 0.00
As of Dec. 13, 2017

IBB Stock Market Capitalization

Giant 16.16%
Large 35.16%
Medium 25.34%
Small 15.60%
Micro 7.75%
As of Dec. 13, 2017

IBB Stock Style Exposure

Large Cap Value 8.72%
Large Cap Blend 18.84%
Large Cap Growth 25.51%
Mid Cap Value 3.39%
Mid Cap Blend 3.17%
Mid Cap Growth 18.83%
Small Cap Value 0.90%
Small Cap Blend 3.63%
Small Cap Growth 17.01%
As of Dec. 13, 2017
View More Holdings

IBB Top 10 Holdings

Symbol Name % Weight Price % Chg
BIIB Biogen Inc 8.78% 327.94 +1.36%
AMGN Amgen Inc 8.38% 177.04 +1.21%
GILD Gilead Sciences Inc 7.69% 75.57 +1.65%
CELG Celgene Corp 6.54% 109.41 +1.08%
REGN Regeneron Pharmaceuticals Inc 5.96% 388.95 +1.52%
ILMN Illumina Inc 4.41% 216.55 +2.70%
VRTX Vertex Pharmaceuticals Inc 3.79% 145.86 +2.34%
ALXN Alexion Pharmaceuticals Inc 3.35% 115.76 +2.36%
MYL Mylan NV 3.26% 40.52 +1.27%
INCY Incyte Corp 3.00% 96.41 +0.46%
As of Dec. 13, 2017
Advertisement

IBB One Page Reports

IBB Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Technology
Fund Owner Firm Name iShares
Benchmark Index
NASDAQ Biotechnology TR USD
100.0%

IBB Manager Info

Name Tenure
Alan Mason 1.63 yrs
Diane Hsiung 9.92 yrs
Greg Savage 9.92 yrs
Jennifer Hsui 5.34 yrs

IBB Net Fund Flows

1M 201.38M
3M 504.95M
6M 1.279B
YTD 763.08M
1Y 748.97M
3Y 3.140B
5Y 4.414B
10Y 4.497B
As of Nov. 30, 2017

IBB Risk Info

Beta (5Y) 1.314
Max Drawdown (All) 62.85%
Historical Sharpe (10Y) 0.7619
Historical Sortino (All) 0.573
30-Day Rolling Volatility 15.47%
Daily Value at Risk (VaR) 1% (All) 4.85%
Monthly Value at Risk (VaR) 1% (All) 19.60%

IBB Fundamentals

Dividend Yield TTM (12-15-17) 0.21%
SEC Yield (12-31-15) 0.00%
Weighted Average PE Ratio 20.35
Weighted Average Price to Sales Ratio 5.895
Weighted Average Price to Book Ratio 4.684
Weighted Median ROE 7.85%
Weighted Median ROA -2.99%
Forecasted Dividend Yield 0.56%
Forecasted PE Ratio 19.81
Forecasted Price to Sales Ratio 4.839
Forecasted Price to Book Ratio 3.743
Number of Holdings 161
As of Dec. 13, 2017

IBB Growth Estimates

Forecasted 5 Yr Earnings Growth 9.84%
Forecasted Book Value Growth 16.20%
Forecasted Cash Flow Growth 16.39%
Forecasted Earnings Growth 12.50%
Forecasted Revenue Growth 14.98%
As of Dec. 13, 2017

IBB Comparables

Edit

IBB Attributes

Key Dates
Inception Date 2/5/2001
Termination Date
Last Annual Report Date 3/31/2017
Last Prospectus Date 12/1/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IBB Excel Add-In Codes

  • Name: =YCI("IBB","name")
  • Broad Asset Class: =YCI("IBB", "broad_asset_class")
  • Broad Category: =YCI("IBB", "broad_category_group")
  • Prospectus Objective: =YCI("IBB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.